Causes of Childhood Blindness in the United States Using the IRIS® Registry (Intelligent Research in Sight)
- PMID: 37037315
- PMCID: PMC10524509
- DOI: 10.1016/j.ophtha.2023.04.004
Causes of Childhood Blindness in the United States Using the IRIS® Registry (Intelligent Research in Sight)
Abstract
Purpose: To investigate causes of childhood blindness in the United States using the IRIS® Registry (Intelligent Research in Sight).
Design: Cross-sectional study.
Participants: Patients ≤ 18 years of age with visual acuity (VA) 20/200 or worse in their better-seeing eye in the IRIS Registry during 2018.
Methods: Causes of blindness were classified by anatomic site and specific diagnoses.
Main outcome measures: Percentages of causes of blindness.
Results: Of 81 164 children with 2018 VA data in the IRIS Registry, 961 (1.18%) had VA 20/200 or worse in their better-seeing eye. Leading causes of blindness were retinopathy of prematurity (ROP) in 301 patients (31.3%), nystagmus in 78 patients (8.1%), and cataract in 64 patients (6.7%). The retina was the leading anatomic site (47.7%) followed by optic nerve (11.6%) and lens (10.0%). A total of 52.4% of patients had treatable causes of blindness.
Conclusions: This analysis offers a unique cross-sectional view of childhood blindness in the United States using a clinical data registry. More than one-half of blind patients had a treatable cause of blindness.
Financial disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Keywords: Childhood blindness; IRIS registry; Retinopathy of prematurity.
Copyright © 2023 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Similar articles
-
United States Population Disparities in Ophthalmic Care: Blindness and Visual Impairment in the IRIS® Registry (Intelligent Research in Sight).Ophthalmology. 2023 Nov;130(11):1121-1137. doi: 10.1016/j.ophtha.2023.06.011. Epub 2023 Jun 17. Ophthalmology. 2023. PMID: 37331480 Free PMC article.
-
Corneal Opacity in the United States: An American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Study.Ophthalmology. 2025 Jan;132(1):52-61. doi: 10.1016/j.ophtha.2024.07.005. Epub 2024 Jul 8. Ophthalmology. 2025. PMID: 38986874
-
An update on progress and the changing epidemiology of causes of childhood blindness worldwide.J AAPOS. 2012 Dec;16(6):501-7. doi: 10.1016/j.jaapos.2012.09.004. J AAPOS. 2012. PMID: 23237744
-
Childhood visual impairment and blindness: 5-year data from a tertiary low vision center in Israel.Eye (Lond). 2022 Oct;36(10):2052-2056. doi: 10.1038/s41433-021-01743-3. Epub 2021 Aug 23. Eye (Lond). 2022. PMID: 34426656 Free PMC article. Review.
-
Causes of blindness and visual impairment in Latin America.Surv Ophthalmol. 2012 Mar-Apr;57(2):149-77. doi: 10.1016/j.survophthal.2011.07.002. Epub 2011 Dec 2. Surv Ophthalmol. 2012. PMID: 22137039 Review.
Cited by
-
Association of Speckle-Based Blood Flow Measurements and Fluorescein Angiography in Infants with Retinopathy of Prematurity.Ophthalmol Sci. 2023 Dec 29;4(4):100463. doi: 10.1016/j.xops.2023.100463. eCollection 2024 Jul-Aug. Ophthalmol Sci. 2023. PMID: 38591050 Free PMC article.
-
Multi-registry analysis of patients with multiple sclerosis and neuromyelitis optica to improve capture of demographic data and compare visual outcomes.Mult Scler Relat Disord. 2024 Apr;84:105499. doi: 10.1016/j.msard.2024.105499. Epub 2024 Feb 11. Mult Scler Relat Disord. 2024. PMID: 38387161 Free PMC article.
-
Nitro-Oleic acid protects from neovascularization, oxidative stress, gliosis and neurodegeneration in oxygen-induced retinopathy.Redox Biol. 2025 Jun;83:103634. doi: 10.1016/j.redox.2025.103634. Epub 2025 Apr 12. Redox Biol. 2025. PMID: 40273475 Free PMC article.
-
Using Natural Language Processing to Identify Different Lens Pathology in Electronic Health Records.Am J Ophthalmol. 2024 Jun;262:153-160. doi: 10.1016/j.ajo.2024.01.030. Epub 2024 Feb 1. Am J Ophthalmol. 2024. PMID: 38296152 Free PMC article.
-
Identifying novel candidate compounds for therapeutic strategies in retinopathy of prematurity via computational drug-gene association analysis.Front Pediatr. 2023 Jul 10;11:1151239. doi: 10.3389/fped.2023.1151239. eCollection 2023. Front Pediatr. 2023. PMID: 37492605 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical